Keflin is a noun that refers to a broad-spectrum antibiotic drug belonging to the cephalosporin group. It is derived from cephalosporin C, which is produced by the fungus Cephalosporium acremonium, initially discovered in a sewage outfall in Sardinia, Italy, in the late 1940s. Keflin is primarily used in the medical field for the treatment of various bacterial infections.
As a cephalosporin antibiotic, keflin works by interfering with the synthesis of the bacterial cell wall, ultimately leading to the disruption of the outer structure of the bacteria. This effect inhibits the growth and proliferation of susceptible bacteria, making it an effective treatment option in many cases.
Keflin is commonly administered through injection, either intravenously or via intramuscular route, depending on the severity of the infection and the patient's condition. It is typically used to treat infections caused by susceptible bacteria, such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, as well as certain types of meningitis.
As with any antibiotic, the use of keflin may be associated with potential side effects, including diarrhea, nausea, vomiting, allergic reactions, and superinfection. It is essential to use keflin only under appropriate medical supervision and following the prescribed dosage and duration of treatment to ensure maximum effectiveness while minimizing adverse effects.
